Consentement d'utilisation des Cookies

J'accepte Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

151-67-7 - 1-Bromo-1-chloro-2,2,2-trifluoroethane, 99% - 2-Bromo-2-chloro-1,1,1-trifluoroethane - Halothane - L10179 - Alfa Aesar

L10179 1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%

Numéro CAS
151-67-7
Synonymes
2-Bromo-2-chloro-1,1,1-trifluoroethane
Halothane

Dimensions Prix ($) Quantité Disponibilité
25g 37,29
100g 93,42
Ajouter au panier Ajouter au devis en vrac Afficher l'article

1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%

MDL
MFCD00009602
EINECS
205-796-5

Propriétés chimiques

Formule
CF3CHBrCl
Poids formulaire
197.39
Point d'ébullition
49-50°
Densité
1.872
Indice de réfraction
1.3691
Sensibilité
Light Sensitive
Solubilité
Soluble in water (8 mg/ml).

Applications

1-Bromo-1-chloro-2,2,2-trifluoroethane has been used in a study that combined molecular simulations with free energy simulations to study solvation of halothane in polarizable water and methanol. It is also used in a study to investigate the interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor. In an effect believed to be independent of anesthesia, halothane inhibits synthesis of 5-hydroxytryptamine in brain tissue, probably at the tryptophan hydroxylase step.

Notes

Light Sensitive. Store in the dark. Store away from oxidizing agents. Incompatible with light and oxidizing agents.

Références bibliographiques

S Bourgoin; J P Ternaux; A Boireau; F Héry; M Hamon. Effects of halothane and nitrous oxide anesthesia on 5-HT turn-over in the rat brain.Naunyn-Schmiedebergs Archives of Pharmacology.1975, 288 (2-3), 109-121.

Travis J A Craddock; Marc St George; Holly Freedman; Khaled H Barakat; Sambasivarao Damaraju; Stuart Hameroff; Jack A Tuszynski. Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia.PLoS ONE.2012, 7 (6), e37251.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H318-H341

Causes serious eye damage. Suspected of causing genetic defects.

Mentions de prudence: P201-P280-P281-P202-P305+P351+P338-P310-P308+P313-P405-P501a

Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. Use personal protective equipment as required. Do not handle until all safety precautions have been read and understood. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/physician. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Autres références

Merck
14,4603
Beilstein
1736947
Code tarifaire harmonisé
2903.79
TSCA
No
RTECS
KH6550000

Recommandé

  • A10221

    Imidazole, 99%
  • L16725

    2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether, 97%
  • L16891

    Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether, 98+%
  • L17285

    2,2-Dichloro-1,1-difluoroethyl methyl ether, 97%
  • L17315

    1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether, 97%

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire